Pancuronium, Org 6368 and gallamine were compared in control cats and in cats with experimental cholestasis. A decrease in the plasma clearance and a prolongation of neuromuscular blockade with Org 6368 and pancuronium were found in the latter; no significant difference was detected in the biotransformation pattern of Org 6368 and pancuronium compared with controls. Inhibition of hepatic uptake of Org 6368 and pancuronium in extrahepatic cholestasis might explain the significant alterations in the pharmacokinetics of the two steroid neuromuscular blocking drugs. The phannacokinetics of gallRmine were normal during cholestasis. The results suggest that, under pathological conditions involving increased plasma concentrations of bile salts, neuromuscular blocking agents that are cleared from the plasma by the liver may have an impaired hepatic uptake and consequently a prolonged duration of action.
either of these processes will affect the pharmacokinetic pattern of such drugs. This may have clinical consequences such as alterations in their duration of action.
In the case of the neuromuscular blocking drugs tubocurarine (Cohen, Brewer and Smith, 1967; Meijer and Scaf, 1968; Meijer et al., 1979) , pancuronium Buzello, 1975) and hexafluorenium (Meijer, Vermeer and Kwant, 1971) , hepatic uptake and secretion appear to be major factors in determining the plasma concentrations. In the cat, hepatic uptake is an important factor in the plasma clearance of a number of steroid neuromuscular blocking agents, such as pancuronium, dacuronium and Org 6368 Agoston et al., 1977) .
We investigated the fate of non-depolarizing neuromuscular blocking agents in extrahepatic cholestasis. Three compounds, known to differ considerably in their elimination pathways (i.e. renal or biliary), were studied: Org 6368, the bisquaternary ammonium compound (2£,16$,-dipiperidino-5a-androstan-3a-ol acetate dimethobromide) differing from pancuronium only in lacking the acetate group at C17 position in the steroid skeleton and having a short duration of action in the cat (Sugrue and Duff, 1973) , mainly as a result of a rapid hepatic uptake (Agoston et al., 1977) ; gallamine triethiodide, which in dog and man is predominantly eliminated by the kidneys (Mushin et al., 1949; Feldman, Cohen and Golling, 1969; Agoston et al., 1978) ; pancuromum, which in cat and man is eliminated by both urinary and binary routes Agoston et al., 1973) .
The dynamics and kinetics of these compounds were investigated in cats with experimentally induced cholestasis and compared with control animals.
MATERIALS AND METHODS

Operative procedures
Ligation of the bile duct was performed under anaesthesia with sodium pentobarbitone anaesthesia (40 mg kg" 1 i.p.), or 2% halodiane in 33% oxygen in nitrous oxide after kctamine 50-100 mg i.m. An endotracheal tube was inserted and the lungs ventilated artificially. A mid-line abdominal incision was made, and the common bile duct was doubly ligated with Perma-Hand Seide 4-0 suture approximately 1 cm from the point of entry to the duodenum. The cystic duct was doubly ligated at the base of the gall-bladder, after which the incision was closed with Perma-Hand Seide. The entire operation took less than 30 min. After the operation, all animals were treated with ampicillin 100-200 mg, i.m. The obstruction of the bile ducts lasted 9-10 days. Shamoperated (all manipulations without ligation) and un-manipulated cats served as controls.
Animal experiments
All experiments were carried out in adult cats (2.8 ± 0.2 kg) of either sex under pentobarbitone anaesthesia (40 mg kg-1 , i.p. plus maintenance doses of 4 mg kg" 1 i.v.). After orotracheal intubation, artificial ventilation with air through a cuffed Magill tube of 5.5 mm external diameter was maintained with a Braun respirator type 1955, set at a rate of 30 b.p.m. and a tidal volume of 10 ml kg-1 . A polythene cannula was introduced into the common bile duct and in the control animals the cystic duct was ligated. Through a low abdominal incision, the urethra and the urinary bladder were visualized and the urethra was cannulated. In order to check the general condition of the cat, e.c.g. (ECG-Pulse Monitor, MS-35; Electrodyne Co. Inc., U.S.A.) and mean arterial pressure (Statham P23D6-transducer; KWS 3085 HSE Electro-Manometer) were monitored. Body temperature was kept constant at 36-38 °C by heating the operating table. Rectal temperature was measured with a thermistor (Electrolaboriet, Copenhagen). To replace fluid loss, glucose (2.5%) and saline (0.45%) were infused through a polythene cannula in the external jugular vein. Neuromuscular studies (isometric twitch tension) were performed on the tibialis anterior muscle which was stimulated through the common peroneal nerve with supramaximal square-wave pulses of 0.2-ms duration at a frequency of 0.1 Hz. The stimulus was supplied from a Grass S88 stimulator and SIU 5 stimulus isolation unit. The tendon of the tibialis anterior muscle was connected to a load cell (UL4-20, Statham), attached to a force-displacement transducer (UC3 Gold Cell, Statham), mounted securely on a Braun-Schuster myograph. The signal was amplified by a Hottinger-Baldwin amplifier (Messtechniek, Darmstadt) and muscle contractions were continuously recorded on a MFE two-channel polygraph (d.c. to 40 Hz, full scale). Pancuronium 0.3 mg kg" 1 , Org 6368 l.Smgkg-1 and gallamine S.Omgkg-1 were injected i.v. over 5 s. Blood, urine and bile samples were collected at fixed intervals. Eight hours after administration of the drugs, the experiments were terminated by removing the liver within 2 min All samples were deep frozen for later chemical analysis.
Neuromuscular studies
The time to the onset of maximum block was defined as the time which elapsed from the injection until the twitch had reached its minimum value. For the duration of action, two indices were used: (a) time from administration of the drug until the return of the twitch tension to 50% of control value (duration 50); (b) time from administration of the drug until . reversal to 90% of control tension (duration 90). Recovery time is defined as the time from the minimum value before recovery to 25, 50 and 75% recovery of control twitch tension (recovery 25, 50, 75) . The recovery rate is the time from 25 to 75% recovery of control twitch tension (recovery rate 25-75) ( fig. 1) 3a-Hydroxysteroid dehydrogenase transforms the 3<x-hydroxyl group on steroids of the C19, C21 and C24 series into their corresponding keto forms, by which NADH is generated from NAD (Mashige, Imai and Osuga, 1976; Osuga et al., 1977) . The reduction equivalents of NADH are transferred to the fluorogen resazurin by the enzyme diaphorase, with formation of the fluorophore resorufin. This substance is measured with an Aminco-Bowman Spectrofluorimeter (Am. Instr. Comp.). Excitation wave length was 565 nm and emission wave length 580 nm. Spectrofluorimetric determinations of pancuronium Org 6368 and gallamine and thin-layer chromatography of these bis(tris)-quaternary ammonium compounds and metabolites have been described in detail elsewhere Agoston et al., 1977; Agoston et al., 1978) .
The fluorimetric method for bisquaternary ammonium compounds does not discriminate between pancuronium, Org 6368 and their deacetylated metabolites(s). Chromatographic quantification of the bisquaternary ammonium compounds in bile and liver homogenate as described previously Agoston et al., 1977) was improved by mixing the samples (1 ml) with 0.1 ml of a saturated copper sulphate solution and removing the precipitated material by centrifugation. The supernatant was used for further chromatographic procedures.
Conjugation
To investigate a possible conjugation of Org 6368 or metabolite(s) with sulphate or glucuronic acid liver homogenates of control cats receiving Org 6368 1.5 mg kg" 1 were analysed. Sulphate conjugation: to 2 ml of liver homogenate (1 mg of tissue in 1 ml Krebs-bicarbonate) 1 ml of Tris-buffer 2 mol litre-1 (pH = 7.4) and 100 (jJitre partially purified bacterial aryl sulphatase solution (Sigma, St Louis, U.S.A.) were added.
Glucuromdation: to 2 nil of liver homogenate, 1 ml of sodium acetate-buffer 0.5 mol litre" 1 (pH = 6.0) and 100 (Jitre of highly purified bacterial glucuronidase solution (Boehringer, Mannheim, West Germany) were added. The mixtures were adjusted to 15 ml with distilled water and incubated for 2.5 h at 37 °C. The same liver homogenates without addition of the enzyme preparations served as controls. Fluorescence of non-enzyme treated and enzyme-treated livers containing Org 6368 or its metabolite(s) were compared. This method is based on the assumption that the polar conjugates of the metabolites) of Org 6368 will not be extracted with Rose-Bengal into the chloroform phase (Buzello, 1975) .
Statistics
All values are given as mean + SEM. Statistical significance was tested using either the paired or the unpaired Student's t test with a 95% significance level.
Pharmacokinetic calculations
The disposition of neuromuscular blocking drugs can be described mathematically by a two-or threecompartment open model (Gibaldi, Levy and Hayton, 1972; McLeod, Watson and Rawlins, 1975; Somogyi, Shanks and Triggs, 1976, Miller et al., 1979) .
Plasma clearance curves were fitted using a computerized program which, after balanced iterative peeling of the curves, yields straight regression lines of log plasma concentration v. time, using the least squares method. Pharmacokinetic model-parameters, such as steady-state volume of distribution (F**), volume of central compartment (VJ and plasma clearance (C/) were calculated according to Wagner (1976) .
RESULTS
Clinical chemistry
There was no impairment of renal glomerular filtration in the cats with extrahepatic cholestasis, as judged by normal plasma concentrations of creatinine and urea. The liver function tests revealed significant increases of the enzymes alkaline phosphatase (AP) and glutamic-pyruvic transaminase (GPT) in the jaundiced cats. Significant increases in the plasma concentrations of total cholesterol and total bilirubin were observed. Approximately 60% of the total bilirubin in the plasma was present as a glucuronide conjugate.
Total bile salt concentrations in plasma, after 9-10 days experimental cholestasis, were increased more than 100-fold as compared with control. Relief of biliary obstruction by cannulation of the common bile duct caused a linear decay of the plasma bile salt concentration, indicating saturation elimination kinetics. After 7 h the concentration was about half the initial value ( fig. 2 ). Total cholesterol concentrations had returned to baseline after 480 min and total bilirubin plasma concentration was decreased by about 40% at that time (table I) .
Pharmacodynamics
The phannacodynamic indices defining the neuromuscular blockade of Org 6368 in cats with experimental chok-stasis differed clearly from those of the control animals, except for the time of onset of action. The same is true, but to a lesser extent, for pancuronium (table II) .
Cholestasis produced a 5.5-fold prolongation of the duration to 90% twitch recovery with Org 6368 compared with controls; for pancuronium this prolongation was only 1.6-fold ( fig. 3 ). In contrast, cholestasis had no influence on the dynamics of gallamine (table II) . Also, no significant differences between un-manipulated control cats and shamoperated cats were found for Org 6368 in this respect (table II) .
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Pharmacokinetics of Org 6368
The pharmacokinetic indices such as the half-lives (7V 1 , 7/ and 7V/), the plasma clearance (C/), the volume of central compartment (V x ) and the steadystate volume of distribution (l^*) of the three quaternary ammonium compounds are given in table IV. For Org 6368, a considerable decrease in plasma clearance and significant increases of the distribution half-life 7V* and of the elimination halflife Tf were found in extrahepatic cholestasis (table  IV, fig. 4 ).
The cumulative urinary excretion of Org 6368 ( fig. 5 ) in extrahepatic cholestasis revealed a profound increase, from 10% to approximately 40% of the (table III) . There were no statistical differences in kinetics between the un-manipulated control cats and the sham-operated cats for Org 6368 (tables III, IV).
Pharmacokinetics of pancuronium
The elimination half-life Tf for pancuronium in extrahepatic cholestasis differed from that in the control cats (table IV, fig. 6 ).
Cumulative urinary excretion of pancuronium showed a 1.8-fold increase compared with control ( fig. 7) .
Pancuronium could not be detected in the bile of cats with cholestasis ( fig. 7) , while the liver content of pancuronium after 8 h was significantly less than in controls (table III) . The total recovery from bile, urine and liver of pancuronium in extrahepatic cholestasis was significantly greater than in the control (table III) .
Pharmacokinetics of gallamine
The pharmacokinetics for gallamine did not show significant differences between the group of cats with extrahepatic cholestasis and the control (tables III, IV, figs 8, 9).
Biotransformation
Thin-layer chromatography of urine, bile and liver samples of cats receiving Org 6368 was performed to obtain more information on biotransformation in extrahepatic cholestasis.
We found that, in extrahepatic cholestasis, Org 6368 is metabolized to its 3-hydroxy derivative to about the same extent as in control cats-approximately 60% of the administered dose after 8 h BRITISH JOURNAL OF ANAESTHESIA (table III) . At the end of the observation period, the livers in both groups contained virtually the 3-hydroxy derivative alone. The metabolism of pancuronium to its hydroxy-derivatives showed a pattern comparable to Org 6368 (table III) .
The fluorimetric yields of livers after enzymatic pretreatment with jS-glucuronidase and aryl-sulphatase did not differ significantly from that of non-enzyme treated livers.
DISCUSSION
The decrease in the plasma clearance and the concomitant prolongation of action of Org 6368 and pancuronium in cats with cholestasis may have several causes.
(a) A decrease in renal clearance. The physicochemical properties of the bis(tris)-quaternary neuromuscular blocking drugs such as their relatively low lipid solubility and moderate protein binding (Meijer and Weitering, 1970; Waser, 1973; Meijer, Weitering and Vonk, 1976; Meijer et al., 1979) explain why renal elimination of such bis(tris)-quaternary drugs occurs by glomerular filtration (Cohen, Brewer and Smith, 1967; Raaflaub and Frey, 1972) . However, renal failure as a cause of the marked decrease in the plasma clearance of the muscle relaxants Org 6368 and pancuronium in extrahepatic cholestasis observed in the present study is not very likely since renal function tests indicate a normal glomerular filtration rate. This conclusion is supported by the finding of normal kinetics of gallamine in the cats with cholestasis.
(b) A decrease in metabolism. Duvaldestin and colleagues (1978) investigated the fate of pancuronium in patients with liver cirrhosis and reported a decrease in the biotransformation of pancuronium to its 3-deacetylated metabolite. Possibly, plasma cholinesterase plays a role in the breakdown of the acetylated steroid compounds and this enzyme is synthetized by the liver (Kalow, 1959; Schuh, 1977) . Biotransformation patterns of Org 6368 and pancuronium in cats with and without cholestasis in the present study were very similar. A similar result was found for pancuronium in man (Somogyi et al., 1977) .
(c) A decrease in biliary excretion. The marked decrease in biliary output of pancuronium and Org 6368 in extrahepatic cholestasis cannot explain the pharmacological behaviour, since biliary excretion in control animals was small for both compounds. The biliary output of gallamine in extrahepatic cholestasis was not significantly different from control.
(d) A decrease in hepatic uptake. Inhibition of this process might explain the decreased plasma clearance of Org 6368 and pancuronium. The following observations point to a" decreased hepatic uptake: the significant decrease in the liver content of pancuronium after 8 h in extrahepatic cholestasis, and the marked decrease in liver to plasma partition ratio for Org 6368.
The data and observations presented here support the concept that cholestasis causes an impairment of the hepatic transport at the uptake level. The mechanism of this effect could be an interaction of the steroid neuromuscular blocking drugs with naturally occurring bile components, most likely bile salts. Several authors reported impairment of biotransformation of drugs during extrahepatic cholestasis, caused by increased concentrations of bile salts (McLuen and Fouts, 1961; Hutterer et al., 1970) . Vonk and others (1978a, b) observed that bile salts at concentrations of about 100 (xmol litre" 1 and greater inhibit hepatocellular uptake of the organic cations tubocurarine and acetyl-procainamide ethcbromide in intact rats, isolated rat livers and isolated hepatocytes. Recently, we have shown a prolongation of the duration of action of Org 6368 by bile salts as a result of inhibition of primary hepatic uptake . The present investigations show that the concentrations of bile salt in plasma after 9-10 days cholestasis were increased from the normal value of 2 (xmol litre" 1 to 500 ysnol litre" 1 . According to previous studies these increased concentrations could very well account for the impaired hepatic uptake of the bisquaternary steroidal agents.
There is no simple explanation for the greater total recovery of Org 6368 and pancuronium and their metabolite(s) in extrahepatic cholestasis. Formation of conjugates with sulphuric or glucuronic acid, or both, could be excluded. Similar findings were obtained (Buzello, 1975) for pancuronium in man. It is possible that changes in distribution in hepatic or extrahepatic tissues, or both, occurred.
The present results confirm the study of Somogyi, Shanks and Triggs (1977) that the use of pancuronium and other steroid neuromuscular blocking drugs in the commonly used dosage regime in patients with extrahepatic cholestasis may cause unexpected prolongation of action. 
